Free Trial

Bio-Techne (TECH) Earnings Date, Estimates & Call Transcripts

Bio-Techne logo
$68.72 +2.35 (+3.54%)
(As of 11/20/2024 ET)

Bio-Techne Latest Earnings Summary

Upcoming Q2
Earnings Date
Feb. 6Estimated
Actual EPS
(Oct. 30)
$0.42 Beat By $0.04
Consensus EPS
(Oct. 30)
$0.38

Bio-Techne announced Q1 2025 earnings on October 30, 2024, reporting an EPS of $0.42, which topped the consensus estimate of $0.38 by $0.04. Quarterly revenue rose 4.5% year-over-year to $289.46 million, above analysts' expectations of $280.22 million. With a trailing EPS of $0.94 and a P/E Ratio of 73.11, Bio-Techne's earnings are expected to grow 20.24% next year, from $1.68 to $2.02 per share.

TECH Upcoming Earnings

Bio-Techne's next earnings date is estimated for Thursday, February 6, 2025, based off prior year's reporting schedules.

Get Bio-Techne Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bio-Techne and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TECH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TECH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bio-Techne Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242$0.40$0.44$0.42
Q2 20242$0.40$0.49$0.45
Q3 20244$0.42$0.55$0.47
Q4 20244$0.47$0.57$0.50
FY 202412$1.69$2.05$1.83
Q1 20252$0.34$0.46$0.40
Q2 20252$0.34$0.49$0.42
Q3 20252$0.48$0.56$0.52
Q4 20252$0.57$0.57$0.57
FY 20258$1.73$2.08$1.91
Q1 20261$0.44$0.44$0.44
Q2 20261$0.45$0.45$0.45
Q4 20261$0.62$0.62$0.62

Bio-Techne Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/6/2025
(Estimated)
------- 
10/30/2024Q1 2025$0.38$0.42+$0.04$0.53$280.22M$289.46M    
8/7/2024Q4 2024$0.49$0.49-$0.73$306.49M$306.10M        
5/1/2024Q3 2024$0.45$0.48+$0.03$0.57$292.36M$303.43M        
2/1/2024Q2 2024$0.36$0.33 -$0.03$0.49$277.48M$272.60M    
10/31/2023Q1 2024$0.39$0.35 -$0.04$0.39$289.81M$276.94M    
8/8/2023Q4 2023$0.49$0.56+$0.07$0.65$304.71M$301.32M    
5/3/2023Q3 2023$0.48$0.53+$0.05$0.51$298.55M$294.15M        
2/2/2023Q2 2023$0.41$0.38 -$0.03$0.45$289.98M$271.58M    

Bio-Techne Earnings - Frequently Asked Questions

Bio-Techne has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates. Learn more on TECH's earnings history.

In the previous quarter, Bio-Techne (NASDAQ:TECH) reported $0.42 earnings per share (EPS) to beat the analysts' consensus estimate of $0.38 by $0.04. Learn more on analysts' earnings estimate vs. TECH's actual earnings.

The conference call for Bio-Techne's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Bio-Techne's latest earnings report can be read online.
Read Transcript

Bio-Techne (NASDAQ:TECH) has a recorded annual revenue of $1.16 billion.

Bio-Techne (NASDAQ:TECH) has a recorded net income of $168.10 million. TECH has generated $0.94 earnings per share over the last four quarters.

Bio-Techne (NASDAQ:TECH) has a trailing price-to-earnings ratio of 73.11 and a forward price-to-earnings ratio of 40.90. The price/earnings-to-growth ratio is 4.93.

Bio-Techne's earnings are expected to grow from $1.68 per share to $2.02 per share in the next year, which is a 20.24% increase.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:TECH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners